Tag Archives: Heart Disease

Health Issues: Middle-Aged Man With Rapid Heart Beat Diagnosed With Sarcoidosis

From a New York Times article by Lisa Sanders, M.D.:

Diagnosis from New York Times by Lisa Sanders, MD Photo Illustration by Ina JangIn sarcoidosis, abnormal collections of cells called granulomas invade the organ, interfering with its normal activity and often destroying the surrounding tissue. What is left is a scar, known as fibrosis, dotted with these abnormal granulomas.

When caught early, sarcoidosis can be treated and the destruction slowed or even stopped. But it was too late for that in this man’s case. He was started on immune-suppressing medications to prevent additional damage, but he needed a new heart.

The man had been active and healthy, until five years earlier when he started to feel tired. His doctor sent him to a cardiologist, who took one look at his EKG and said he needed a pacemaker, right away. He got one the next day. He was fine for a year, and then, on a business trip to Atlanta, he suddenly felt lightheaded, and his heart fluttered wildly in his chest. In the E.R. they told him his heart was beating 220 beats a minute. You should be dead, one doctor said.

To read more click on the following link: https://www.nytimes.com/2019/08/22/magazine/why-was-the-middle-aged-mans-heart-beating-so-dangerously-fast.html

Drug Studies: Polypill Strategy (Including Aspirin) Proves “Effective In Preventing Major Cardiovascular Events”

From The Lancet issue August 24, 2019:

Polypill illustration from Harvard HealthUse of polypill was effective in preventing major cardiovascular events. Medication adherence was high and adverse event numbers were low. The polypill strategy could be considered as an additional effective component in controlling cardiovascular diseases, especially in LMICs.

When restricted to participants in the polypill group with high adherence, the reduction in the risk of major cardiovascular events was even greater compared with the minimal care group…

A fixed-dose combination therapy (polypill strategy) has been proposed as an approach to reduce the burden of cardiovascular disease, especially in low-income and middle-income countries (LMICs). The PolyIran study aimed to assess the effectiveness and safety of a four-component polypill including aspirin, atorvastatin, hydrochlorothiazide, and either enalapril or valsartan for primary and secondary prevention of cardiovascular disease.

To read more click on the following link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31791-X/fulltext

Health Studies: Short Sleep Duration And Sleep Disorders Have Adverse Effects On Heart Health

From a Circulation online release:

Average hours of nightly sleep…these results indicate that sleep may play an important role in health disparities and may represent a modifiable risk factor (along with diet and physical activity) for cardiometabolic risk in general and cardiometabolic health disparities specifically.

Statement Summary

Our review of the epidemiological data on the impact of sleep duration and disorders on cardiovascular health suggests the following:

  1. Both short- and long-duration sleep and sleep disorders such as SDB and insomnia are associated with adverse cardiometabolic risk profiles and outcomes.

  2. Sleep restriction has a negative impact on energy balance, but it is less clear whether treating sleep disorders has a positive impact on obesity risk.

  3. Treating those with sleep disorders may provide clinical benefits, particularly for blood pressure.

Sleep is increasingly recognized as an important lifestyle contributor to health. However, this has not always been the case, and an increasing number of Americans choose to curtail sleep in favor of other social, leisure, or work-related activities. This has resulted in a decline in average sleep duration over time. Sleep duration, mostly short sleep, and sleep disorders have emerged as being related to adverse cardiometabolic risk, including obesity, hypertension, type 2 diabetes mellitus, and cardiovascular disease.

To read more click on the following link: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000444

Boomers Health Tips: C-Reactive Protein (CRP) Blood Tests Can Help Predict Heart Disease

From a Harvard Medical School “Harvard Heart Letter”:

Understanding Inflamation Harvard HealthChronic inflammation often begins with a similar cellular response but morphs into a lingering state that persists far longer. Toxins such as cigarette smoke or an excess of fat cells (especially around the belly area) can also trigger inflammation. So can the fatty plaque inside arteries, which causes inflammatory cells to cover and wall off the plaque from the flowing blood. But the plaque may rupture, mingle with blood, and form a clot. These clots are responsible for the majority of heart attacks and most strokes.

A buildup of cholesterol-rich plaque inside arteries — known as atherosclerosis — is the root cause of most heart attacks and strokes. Researchers have long recognized that chronic inflammation sparks this artery-damaging process (see “Understanding inflammation”). Now, they’re zeroing in on better ways to tackle that aspect of the problem.

Addressing inflammation is vital. Even when people take steps to lower their risks for heart disease, such as reducing their cholesterol and blood pressure, they may still face life-threatening cardiovascular events.

Click on following link to read more: https://www.health.harvard.edu/heart-health/new-insights-about-inflammation